Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
Rossetti A, Petragnano F, Milazzo L, Vulcano F, Macioce G, Codenotti S, Cassandri M, Pomella S, Cicchetti F, Fasciani I, Antinozzi C, Di Luigi L, Festuccia C, De Felice F, Vergine M, Fanzani A, Rota R, Maggio R, Polimeni A, Tombolini V, Gravina GL, Marampon F. Rossetti A, et al. Among authors: cicchetti f. Int J Radiat Biol. 2021;97(7):943-957. doi: 10.1080/09553002.2021.1928786. Epub 2021 Jun 4. Int J Radiat Biol. 2021. PMID: 33979259
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
Cassandri M, Pomella S, Rossetti A, Petragnano F, Milazzo L, Vulcano F, Camero S, Codenotti S, Cicchetti F, Maggio R, Festuccia C, Gravina GL, Fanzani A, Megiorni F, Catanoso M, Marchese C, Tombolini V, Locatelli F, Rota R, Marampon F. Cassandri M, et al. Among authors: cicchetti f. Int J Mol Sci. 2021 Oct 1;22(19):10671. doi: 10.3390/ijms221910671. Int J Mol Sci. 2021. PMID: 34639012 Free PMC article.
Corrigendum to "Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease" [Neurobiology of Disease, 2024 Jan:190:106376].
Bartl S, Xie Y, Potluri N, Kesineni R, Hencak K, Cengio LD, Balazs K, Oueslati A, Parth M, Salhat N, Siddu A, Smrzka O, Cicchetti F, Staffler G, Hayden MR, Southwell AL. Bartl S, et al. Among authors: cicchetti f. Neurobiol Dis. 2024 Apr;193:106444. doi: 10.1016/j.nbd.2024.106444. Epub 2024 Feb 24. Neurobiol Dis. 2024. PMID: 38402018 Free article. No abstract available.
Plasma GFAP and its association with disease severity in Huntington's disease.
Tan K, Alpaugh M, Ashton NJ, Chouinard S, Barker RA, Blennow K, Zetterberg H, Cicchetti F, Benedet AL. Tan K, et al. Among authors: cicchetti f. J Neurol. 2024 Apr;271(4):2108-2113. doi: 10.1007/s00415-023-12109-y. Epub 2023 Nov 18. J Neurol. 2024. PMID: 37979092 No abstract available.
Tau: a biomarker of Huntington's disease.
Lepinay E, Cicchetti F. Lepinay E, et al. Among authors: cicchetti f. Mol Psychiatry. 2023 Oct;28(10):4070-4083. doi: 10.1038/s41380-023-02230-9. Epub 2023 Sep 25. Mol Psychiatry. 2023. PMID: 37749233 Review.
Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24].
Rieux M, Alpaugh M, Salem S, Siddu A, Saint-Pierre M, Denis HL, Rohweder H, Herrmann F, Bazenet C, Lacroix S, Cicchetti F. Rieux M, et al. Among authors: cicchetti f. Neurobiol Dis. 2023 Oct 15;187:106289. doi: 10.1016/j.nbd.2023.106289. Epub 2023 Sep 16. Neurobiol Dis. 2023. PMID: 37722998 Free article. No abstract available.
141 results